The short answer: In chronic kidney disease (CKD), statins and fibrates serve different purposes. Statins are primarily used to reduce cardiovascular risk and are generally the foundation of lipid treatment for appropriate patients with CKD. Fibrates are more effective at lowering triglycerides, but their use becomes more complicated as kidney function declines because they can … Read more
The short answer: Statins are generally an important part of cardiovascular risk management for many people with moderate to severe chronic kidney disease (CKD). Having CKD does not automatically make statins unsafe or mean they will damage the kidneys. The important distinction is that statins are used mainly to reduce cardiovascular risk, not to directly … Read more
The short answer Proton pump inhibitors (PPIs) can cause acute interstitial nephritis (AIN), a form of inflammatory kidney injury, but this is an uncommon complication. It does not mean that everyone taking a PPI will develop kidney disease. Common PPIs include omeprazole, pantoprazole, esomeprazole, lansoprazole, and rabeprazole. They reduce stomach acid and are widely used … Read more
The short answer Chronic kidney disease (CKD) can change how long certain antibiotics remain in the body. When the kidneys clear a drug more slowly, the same dose may produce higher or more prolonged drug exposure. This is particularly important with aminoglycosides such as gentamicin and amikacin and with vancomycin, because excessive exposure can increase … Read more
The short answer Modern contrast dye does not automatically damage the kidneys. The risk depends strongly on the type of contrast, how it is given, your kidney function, and your overall medical condition. There is also an important terminology issue. A rise in creatinine after contrast is often called contrast-associated acute kidney injury (CA-AKI), but … Read more